Prevalence and Dynamics of Circulating Tumor DNA (ctdna) among Patients (pts) with HER2+ Breast Cancer (BC) Receiving Neoadjuvant Paclitaxel/trastuzumab/pertuzumab (THP) in the DAPHNe Trial.
Journal of Clinical Oncology（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined